Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVECHO BIOTECHNOLOGY LIMITED Director's Dealing 2008

Oct 2, 2008

64468_rns_2008-10-02_3aaf8c86-9969-47fa-a1d2-461f2604a4b8.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [149 x 115] intentionally omitted <==

3 October 2008

THE MANAGER COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED

Dear Sir

PHOSPHAGENICS LIMITED

CHANGE OF DIRECTOR’S INTEREST NOTICE – PROFESSOR J MILLS

Attached for release to the market is an Appendix 3Y Notice advising of an increase in the entitlement of Professor Mills to the Company’s ordinary fully paid shares. Such change in interest occurring on Wednesday 1 October and Thursday 2 October 2008 and arising from the purchase on-market of a total 100,000 ordinary fully paid Phosphagenics Limited shares at A$0.07 a share.

Yours faithfully Phosphagenics Limited

==> picture [177 x 54] intentionally omitted <==

per Mourice Garbutt Company Secretary poh\asx\3y jm1 03 10 08

Phosphagenics Limited

ACN 056 482 403 ABN 32 056 482 403

Level 2, 90 William Street Melbourne VIC 3000 Telephone: 61 3 9605 5900 Facsimile: 61 3 9605 5999 Web page: www.phosphagenics.com Email: [email protected]

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PHOSPHAGENICS LIMITED ABN 32 056 482 403

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MILLS, John

Date of last notice 22 May 2008 (Appendix 3Y)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest REFER ANNEXURE “A”
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
REFER ANNEXURE “A”
Date of change REFER ANNEXURE “A”
No. of securities held prior to change REFER ANNEXURE “A”
Class REFER ANNEXURE “A”
Number acquired REFER ANNEXURE “A”
Number disposed NOT APPLICABLE
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
REFER ANNEXURE “A”
No. of securities held after change REFER ANNEXURE “A”
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue
of
securities
under
dividend
reinvestment
plan,
participation in buy-back
REFER ANNEXURE “A”
  • See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract NOT APPLICABLE
Nature of interest NOT APPLICABLE
Name of registered holder
(if issued securities)
NOT APPLICABLE
Date of change NOT APPLICABLE
No. and class of securities to which interest
related prior to change
Note: Details are only required for a contract
in relation to which the interest has changed
NOT APPLICABLE
Interest acquired NOT APPLICABLE
Interest disposed NOT APPLICABLE
Value/Consideration
Note: If consideration is non-cash, provide
details and an estimated valuation
NOT APPLICABLE
Interest after change NOT APPLICABLE

3 October 2008

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 3

APPENDIX 3Y Annexure “A”

3 October 2008

SCHEDULE OF DIRECTORS INTERESTS

PHOSPHAGENICS LIMITED

ASX CODE PREVIOUS
Appendix 3Y
(22/05/08)
PREVIOUS
Appendix 3Y
(22/05/08)
PRESENT
Appendix 3Y
(02/10/08)
PRESENT
Appendix 3Y
(02/10/08)
SHARES OPTIONS SHARES OPTIONS
POH POHOB POH POHOB
Name of Registered Holder(s)
Prof. John Mills and
Prof.SuzanneMary Crowe (1)
164,667 Nil 164,667 Nil
Prof. John Mills and
Prof. Suzanne Mary Crowe
A/C>(2)
212,000 Nil 312,000 Nil
TOTAL ENTITLEMENTS: 376,667 Nil 476,667 Nil
Total Issued Securities 663,542,406 59,630,948 663,542,406 59,630,948
Percentage entitlements 0.0568 NIL 0.0718 NIL

COMMENTS:

1 Professor Mills has a legal and beneficial entitlement to the securities registered in the above joint holding with Professor Suzanne Mary Crowe.

Movement in Entitlements: Shares
Balance, per Appendix 3Y, 22/05/08 164,667
Movement(s) Nil
Balance, per Appendix 3Y, 02/10/08 164,667
2
Professor Mills is a beneficiary under thePortsea Superannuation
Fund:
Movement in Entitlements: Portsea Superannuation Fund Shares
Balance, per Appendix 3Y, 22/05/08 212,000
Movement(s):
Acquisition(s): on-market during normal course of trading of the
official lists of the ASX Limited
01/10/08 at A$0.07 a share 88,900
02/10/08 at A$0.07 a share 11,100
Balance, per Appendix 3Y, 02/10/08 312,000
poh\asx\3y jm 03/10/08